Traditional and Novel Biochemical Markers in Diagnosis and Monitoring of Diabetes

Emel Şahin 1 * , Müfide Öncel 1
More Detail
1 Mevlana Üniversitesi Tıp Fakültesi Tıbbi Biyokimya Anabilim Dalı, Konya
* Corresponding Author
EUR J BASIC MED SCI, Volume 4, Issue 3, pp. 66-73. https://doi.org/10.21601/ejbms/9223
OPEN ACCESS
Download Full Text (PDF)

ABSTRACT

Diabetes with an increasing rate in all over the world, cause high rates of mortality and morbidity, besides high costs for medical treatment of the patients and workforce loss. Because the disease has individual and social effects, it should be diagnosed earlier as far as possible and establishment of necessary lifestyle changes is extremely important. For this purpose, fast, easy and inexpensive diagnostic approaches are obligatory. Scientists are seeking novel parameters for diagnosis of diabetes. Oral glucose tolerance test (OGTT) has been used in diagnosis of diabetes for many years, and cut-off values for glucose in this test are updated by WHO and ADA frequently. Probably, novel parameters suggested as alternative to OGTT will be used routinely by clinicians in the near future.
Keywords: diabetes, diagnosis, monitoring, biochemical markers

CITATION

Şahin E, Öncel M. Traditional and Novel Biochemical Markers in Diagnosis and Monitoring of Diabetes. Eur J Basic Med Sci. 2014;4(3):66-73. https://doi.org/10.21601/ejbms/9223

REFERENCES

  • Diabetes Mellitus Tanı, Sınıflama Ve İzlem İlkeleri. Ulusal Diyabet Kongresi Konsensus Grubu Diyabet Tanı ve Tedavi Rehberi Kursları, 2012.
  • Canivell S, Gomis R. Diagnosis and classification of autoimmune diabetes mellitus. Autoimmunity Reviews 2014;13:403–7.
  • Paschke A, Grzelka A, Zawada A, Zozulińska-Ziółkiewicz D. Clinical characteristics and autoantibody pattern in newly diagnosed adult- onset autoimmune diabetes. Pol Arch Med Wewn 2013; 123 (7-8): 401-8.
  • Devendra D, Liu E, Eisenbarth G S. Type 1 diabetes: recent developments. BMJ 2004; 328: 750–54.
  • Daneman D. Type 1 diabetes. Lancet 2006; 367: 847–58.
  • d’Annunzio G, Marchia M, Aloi C, Salina A, Lugani F, Lorini R. Hyperglycaemia and b-cell antibodies: Is it always pre-type 1 diabetes? Diabetes Research and Clinical Practice 2013; e20-2.
  • Redondo M J, Fain P R, Eisenbarth G S. Genetics of type 1A diabetes. Recent Prog Horm Res 2001; 56: 69–89.
  • Sacks D B, Arnold M, Bakrıs G L, Bruns D E, Horvath A R, Kırkman M S, Lernmark A, Metzger B E, Nathan D M. Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus. Diabetes Care 2011;34:e61–99.
  • Çakır E. Gestasyonel Diabetes Mellitus Tanısı. Selçuk Tıp Dergisi 2014; 30(1): 39-41.
  • Diabetes Mellitus ve Komplikasyonlarının Tanı, Tedavi ve İzlem Kılavuzu. Türkiye Endokrinoloji ve Metabolizma Derneği, 2013.
  • Gülbahar Ö, Çaycı A B, Budakoğlu Ü, Ersin U, Bukan N, Paşaoğlu H, Nas T. Gestasyonel Diabetes Mellitus Tanısı İçin OGTT Değerlendirmesinde ADA Kriterlerinin Yeri. Türk Klinik Biyokimya Dergisi 2010; 8(2): 63-7.
  • Adam B, Yiğitoğlu M R. Tıbbi Biyokimya. Atlas Yayınları. 2012; 133,244
  • Burtis C A, Ashwood E R. Tietz Textbook of Clinical Chemistry Third Edition. W.B Saunders Company. 796-8,1814.
  • Çaycı T, Akgül E Ö, Kurt Y G, Ağıllı M, İspir E, Türker T, Taşlıpınar A, Yaman H, Çakır E, Bilgi C, Erbil M K. Diabetes Mellituslu Hastalarda 24 Saatlik, Anlık ve Gecelik İdrarlarda Mikroalbumin Ölçümü. Fırat Tıp Dergisi 2010;15(2): 92-5.
  • Singh V P, Bali A, Singh N, Singh Jaggi A. Advanced Glycation End Products and Diabetic Complications. Korean J Physiol Pharmacol. 2014; Vol 18: 1－14, February.
  • Busch M, Franke S, Rüster C, Wolf G. Advanced glycation end-products and the kidney. Eur J Clin Invest 2010; 40: 742-55.
  • Hinmana R M, Smith M J, Cambier J C. B cells and type 1 diabetes in mice and men. Immunol Lett 2014; 01.010.
  • Salman S, Satman İ. Diyabete Özgü Antikorlar ve Klinik Pratikte Kullanımları. Turkish Journal of Endocrinology and Metabolism. 2011; 15: 8-12.
  • Tülek N. Diyabet ve İmmün Sistem. Türk Klinik Mikrobiyoloji ve İnfeksiyon Hastalıkları Derneği.II.Ulusal Diyabetik Ayak İnfeksiyonları Sempozyumu, 2012.
  • Yu L, Dong F, Miao D, Fouts A R, Wenzlau J M, Steck A K. Proinsulin/Insulin Autoantibodies Measured With Electrochemiluminescent Assay Are the Earliest Indicator of Prediabetic Islet Autoimmunity. Diabetes Care 2013; 36:8 2266-70.
  • Vardi P, Ziegler A G, Mathews J H, et al. Concentration of insulin autoantibodies at onset of type I diabetes. Inverse log-linear correlation with age. Diabetes Care 1988;11: 736–9.
  • Chao C, Huang G, Lı X, Yang L, Lın J, Jın P, Luo S, Zhang Y, Pan L, Zhou Z. Change of glutamic acid decarboxylase antibody and protein tyrosine phosphatase antibody in Chinese patients with acute-onset type 1 diabetes mellitus. Chinese Medical Journal 2013; 126 (21).
  • Wenzlau J M, Juhl K, Yu L, Moua O, Sarkar S A, Gottlieb P, Rewers M, Eisenbarth G S, Jensen J, Davidson H W, and Hutton J C. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc Natl Acad Sci USA 2007; Oct 23;104(43):17040-5.
  • Altaş S, Gürsu M F, Bulmuş F G. Adipoz Dokudan Salınan Yeni Adipokinler. Fırat Sağlık Hizmetleri Dergisi 2011; 6: 17.
  • Steppan C M, Lazar M A. Resistin and obesity-associated insulin resistance. Trends Endocrinol Metab. 2002; Jan-Feb;13(1):18-23.
  • Verma S, Li S H, Wang C H, Fedak P W, Li R K, Weisel R D, Mickle D A.Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction. Circulation 2003; 12;108(6):736-40.
  • Mather K J, Funahashi T, Matsuzawa Y, Edelstein S, Bray G A, Kahn S E, Crandall J, Marcovina S, Goldstein B, Goldberg R. Adiponectin, Change in Adiponectin, and Progression to Diabetes in the Diabetes Prevention Program. Diabetes 2008; 57(4): 980–6.
  • Yiğitbaşı T, Baskın Y, Afacan G, Harmanda A. Obez Hastalarda Büyüme Hormonu, Leptin, Amilin, Glukagon Benzeri Peptid-1 Seviyeleri ile İnsülin Direnci Arasındaki İlişki. Türk Biyokimya Dergisi 2010; 35 (3) ; 177–82.
  • Lee C Y, Lee C H, Tsai S, Huang C T, Wu M T, Tai S Y, Lin F F, Chao N C, Chang C J. Association between serum leptin and adiponectin levels with risk of insulin resistance and impaired glucose tolerance in non-diabetic women. Med Sci 2009; 25(3): 116-25.
  • Koca C, Nilgün Altan N, Sepici Dincel A, Kosova F, Şahin D, Arslan M. Tip 1 ve Tip 2 Diyabetik Hasta Serumlarında Oksidatif Stres ve Leptin Düzeylerinin İncelenmesi. Türk Klinik Biyokimya Dergisi 2008; 6(3): 99-107.